RECCHIA, FABIO ANASTASIO
 Distribuzione geografica
Continente #
NA - Nord America 19.555
EU - Europa 12.027
AS - Asia 6.275
SA - Sud America 1.272
AF - Africa 96
Continente sconosciuto - Info sul continente non disponibili 85
OC - Oceania 36
AN - Antartide 1
Totale 39.347
Nazione #
US - Stati Uniti d'America 19.039
GB - Regno Unito 3.360
RU - Federazione Russa 2.503
SG - Singapore 2.485
CN - Cina 1.827
IT - Italia 1.321
UA - Ucraina 1.280
DK - Danimarca 1.118
BR - Brasile 1.096
DE - Germania 1.071
VN - Vietnam 777
HK - Hong Kong 647
SE - Svezia 448
CA - Canada 430
FI - Finlandia 243
IE - Irlanda 196
FR - Francia 139
PL - Polonia 100
IN - India 91
EU - Europa 84
JP - Giappone 77
NL - Olanda 73
MX - Messico 69
AR - Argentina 65
BD - Bangladesh 64
ID - Indonesia 59
IL - Israele 49
EC - Ecuador 43
TR - Turchia 38
ZA - Sudafrica 38
ES - Italia 37
IQ - Iraq 36
CH - Svizzera 29
AU - Australia 26
AT - Austria 24
LT - Lituania 19
UZ - Uzbekistan 18
CO - Colombia 16
KR - Corea 16
PK - Pakistan 15
VE - Venezuela 14
MA - Marocco 13
PT - Portogallo 13
CL - Cile 12
PY - Paraguay 12
RO - Romania 12
AE - Emirati Arabi Uniti 11
BE - Belgio 11
SA - Arabia Saudita 11
NZ - Nuova Zelanda 9
EG - Egitto 8
KE - Kenya 8
TN - Tunisia 8
UY - Uruguay 8
AZ - Azerbaigian 7
IR - Iran 6
AO - Angola 5
AL - Albania 4
KZ - Kazakistan 4
NP - Nepal 4
PH - Filippine 4
RS - Serbia 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
BA - Bosnia-Erzegovina 3
CI - Costa d'Avorio 3
GE - Georgia 3
HU - Ungheria 3
JM - Giamaica 3
JO - Giordania 3
LB - Libano 3
NG - Nigeria 3
PE - Perù 3
SN - Senegal 3
BG - Bulgaria 2
BH - Bahrain 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
GA - Gabon 2
GR - Grecia 2
KG - Kirghizistan 2
MD - Moldavia 2
MY - Malesia 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
QA - Qatar 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
AQ - Antartide 1
BB - Barbados 1
BO - Bolivia 1
BY - Bielorussia 1
DM - Dominica 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GD - Grenada 1
GY - Guiana 1
HN - Honduras 1
Totale 39.333
Città #
Dallas 2.929
Southend 2.638
Woodbridge 1.900
Ann Arbor 1.698
Chandler 1.253
Singapore 1.186
Houston 1.151
Beijing 875
Fairfield 793
San Mateo 790
Dearborn 657
Ashburn 639
Jacksonville 631
Hong Kong 544
Falls Church 455
Seattle 454
Moscow 392
Wilmington 390
Cambridge 384
Wayne 330
Boardman 261
Dong Ket 255
Stevenage 252
Los Angeles 248
Hefei 222
Portsmouth 219
The Dalles 218
Lawrence 208
Pisa 197
Dublin 176
Chicago 147
Ho Chi Minh City 131
Brooklyn 130
Beauharnois 121
Ottawa 121
Redwood City 118
São Paulo 106
New York 102
Montréal 91
Warsaw 89
Guangzhou 84
Hanoi 79
Santa Clara 79
Buffalo 71
San Diego 70
Old Bridge 69
Munich 68
Tokyo 65
London 60
Rome 58
Salt Lake City 49
Columbus 48
Milan 45
Tel Aviv 45
Norwalk 41
Council Bluffs 37
Stockholm 35
Montreal 33
Denver 32
Rio de Janeiro 32
Florence 31
Johannesburg 29
Phoenix 29
Elk Grove Village 27
San Francisco 27
Mexico City 26
Orem 26
Atlanta 25
Belo Horizonte 23
Poplar 23
Turku 23
Cascina 22
Chennai 22
Curitiba 22
Helsinki 22
Boston 21
Fremont 21
Brasília 20
Paris 20
Haiphong 19
Tampa 19
Toronto 19
Foggia 18
Manchester 18
Nuremberg 18
Porto Alegre 18
Baghdad 17
Buti 17
Tashkent 17
Augusta 16
Redondo Beach 16
Shenzhen 16
Dhaka 15
Istanbul 15
Miami 15
Philadelphia 15
Quito 15
Caserta 14
Genoa 14
Jakarta 14
Totale 25.405
Nome #
Tachycardia-induced metabolic rewiring as a driver of contractile dysfunction 529
Magnetic resonance imaging of infarct-induced canonical wingless/integrated (Wnt)/β-catenin/T-cell factor pathway activation, in vivo. 375
3D CMR Mapping of Metabolism by Hyperpolarized 13C-Pyruvate in Ischemia–Reperfusion 364
A new dual-promoter system for cardiomyocyte-specific conditional induction of apoptosis 348
Surgical Access and Stimulation of the Pig Pudendal Nerve to Restore Bladder Dysfunctions 328
A Dose-Response Elevation in Hepatic Glucose Uptake is Paralleled by Liver Triglyceride Synthesis and Release. 313
Enabling MSI-Guided Laser Capture Microdissection 301
Cardiac adeno-associated virus 9-mediated delivery of nestin-640 prevents myocardial remodeling in a rodent model of post-ischemic heart failure 300
MicroRNA therapy stimulates uncontrolled cardiac repair after myocardial infarction in pigs 294
Molecular Advances in Reporter Genes: The Need to Witness the Function of Stem Cells in Failing Heart in Vivo. 282
Acetylation mediates Cx43 reduction caused by electrical stimulation 282
A partial knockdown of glucose-6-phosphate dehydrogenase impairs cardiac contractile performance and efficiency, in vivo 279
AAV-Mediated Delivery of VEGF-B Preserves Viability and Cardiac Function Following Myocardial Infarction through a Direct Effect on Cardiomyocyte Survival and Contractility 279
Acute vagal stimulation attenuates cardiac metabolic response to beta-adrenergic stress. 277
REGIONAL MAPPING OF MYOCARDIAL HIBERNATION PHENOTYPE IN IDIOPATHIC END-STAGE DILATED CARDIOMYOPATHY 273
An Implantable ZigBee Ready Telemetric Platform For In Vivo Monitoring Of Physiological Parameters 272
Adaptation and optimization of an intraneural electrode to interface with the cervical vagus nerve 253
Gene Therapy for Heart Failure: New Perspectives 252
Placental stem cells pre-treated with hyaluronan-butyric-retinoic ester to cure infarcted pig hearts: a multimodal study. 251
Pathogenic role of mitochondrial calcium uniporter upregulation in the failing heart: Ca2+ mishandling or what else? 251
Acute and Chronic Increases of Circulating FSTL1 Normalize Energy Substrate Metabolism in Pacing-Induced Heart Failure 244
Acute NO synthase inhibition profoundly alters myocardial oxidation of free fatty acids and glucose in conscious dogs 243
Real time cardiac metabolism assessed with hyperpolarized [1-13C] acetate in a large animal model 241
Analysis of Serum Cholesterol Efflux Capacity in a Minipig Model of Nonischemic Heart Failure 241
Severe mechanical dyssynchrony causes regional hibernation-like changes in pigs with nonischemic heart failure. 240
Abnormal stress-induced myocardial metabolic changes in patients with dilated cardiomyopathy. 236
A fast and accurate learning-based decoding algorithm for the classification of cardiovascular and respiratory challenges using intraneural electrodes in the pig vagus nerve 235
Acute NO synthase inhibition increases the activities of myocardial glyceraldehyde-3-phosphate-dehydrogenase and malonyl-CoA-decarboxylase in conscious dogs. 235
Acute and chronic endothelial dysfunction: implications for the development of heart failure. 233
Neural stimulation hardware for the selective intrafascicular modulation of the vagus nerve 232
A lightweight learning-based decoding algorithm for intraneural vagus nerve activity classification in pigs 232
Multimodal molecular imaging system for pathway-specific reporter gene expression 231
Q-PINE: A quick to implant peripheral intraneural electrode 231
A novel endothelial mechanism that counteracts arteriolar constriction. 230
Low HDL - high inflammatory markers in heart failure induced by high frequency pacing in minipigs. 225
ACE-inhibitor, modulates myocardial glucose uptake via B2-kinin receptor-mediated cardiac NO production in Langendorff mouse heart. 225
Expression of C-type natriuretic peptide and of its receptor NPR-B in normal and failing heart. 224
DNP methods for cardiac metabolic imaging with hyperpolarized [1-13C]pyruvate large dose injection in pigs 223
Cardiovascular Molecular Imaging with Hyperpolarized [1-13C] acetate and [1-13C] pyruvate in middle size animal model 221
Ferritin as a reporter gene for in vivo tracking of stem cells by 1.5T cardiac MRI in a rat model of myocardial infarction 219
Acute Vagal Stimulation Attenuates Cardiac Metabolic Response to Beta-adrenergic Stress in Chronically Instrumented Dogs. 218
Proteomics-based network analysis characterizes biological processes and pathways activated by preconditioned mesenchymal stem cells in cardiac repair mechanisms 218
Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy. 215
Mass Spectrometry Imaging as a Tool to Investigate Region Specific Lipid Alterations in Symptomatic Human Carotid Atherosclerotic Plaques 215
Altered cardiac metabolic phenotype after prolonged inhibition of NO synthesis in chronically instrumented dogs. 212
Adaptive induction of NF-E2–Related Factor-2-driven antioxidant genes in endothelial cells in response to hyperglycemia 212
Modulating Fatty Acid Oxidation in Heart Failure 212
A software tool for the real-time in vivo evaluation of neural electrodes' selectivity 212
LOW HDL-HIGH INFLAMMATORY MARKERS IN HEART FAILURE INDUCED BY HIGH FREQUENCY PACING IN MINIPIGS 209
Beneficial effects of acute inhibition of the oxidative pentose phosphate pathway in the failing heart. 207
Carnitine palmitoyl transferase-I inhibition prevents ventricular remodeling and delays decompensation in pacing-induced heart failure 204
Glucose-6-phosphate dehydrogenase-derived NADPH fuels superoxide production in the failing heart. 204
Reduced cardiac NO production during pacing-induced heart failure 204
Follistatin-like 1 promotes cardiac fibroblast activation and protects the heart from rupture 204
Diverse protein kinase A-dependent myofilament protein phosphorylation in the background of regional contractile dysfunction in pacing-induced heart failure 203
Early mechanical dyssynchrony induced by unipolar left ventricular pacing is unrelated to myocardial flow and metabolism 202
Reduced synthesis of NO causes marked alterations in myocardial substrate metabolism in conscious dogs 201
Glucose-6-Phosphate Dehydrogenase Deficiency Increases Myocardial Redox Stress and Moderately Accelerates the Development of Heart Failure 200
Pathologic pulse pressure in isolated coronary artery bed augments flow in vivo despite constant ventricular workload 198
Sequencing and cardiac expression of natriuretic peptide receptor 2 (NPR-B) in Sus Scrofa. 195
Enhanced caveolae-mediated endocytosis by diagnostic ultrasound in vitro. 194
Control of autocrine and paracrine myocardial signals: an emerging therapeutic strategy in heart failure. 194
Impact of glucose-6-phosphate dehydrogenase deficiency on the pathophysiology of cardiovascular disease. 194
Chronic inhibition of nitric oxide synthase alters cardiac substrate handling: underestimating changes in metabolism. 194
Reduced left ventricular compliance and mechanical efficiency after prolonged inhibition of NO synthesis in conscious dogs. 193
Kinin-mediated coronary nitric oxide production contributes to the therapeutic action of angiotensin-converting enzyme and neutral endopeptidase inhibitors and amlodipine in the treatment in heart failure. 192
Nitric oxide-mediated arteriolar dilation after endothelial deformation 191
Pre-treatment of human mesenchymal stem cells with a chemical inductor of cardiogenesis increases their effects on regional myocardial function in a swine model of myocardial infarction. 191
Intracoronary Cytoprotective Gene Therapy: A Study of VEGF-B167 in a Pre-Clinical Animal Model of Dilated Cardiomyopathy 191
Paradoxical downregulation of the glucose oxidation pathway despite enhanced flux in severe heart failure. 190
Nestin is a key regulator of cardioprotection and nestin-640 gene therapy rescues infarcted myocardium 190
Intracoronary gene delivery of the cytoprotective factor vascular endothelial growth factor-B167 in canine patients with dilated cardiomyopathy: A short-term feasibility study 189
Systolic flow augmentation in hearts ejecting into a model of stiff aging vasculature. Influence on myocardial perfusion-demand balance. 187
Early long-term L-T3 replacement rescues mitochondria and prevents ischemic cardiac remodeling in rats. 187
Stem cells transduction with ferritin as a reporter gene to track their fate by 1.5 Tesla MRI, in the beating heart. 187
Animal models of dilated cardiomyopathy for translational research. 186
Mismatch between uniform increase in cardiac glucose uptake and regional contractile dysfunction in pacing-induced heart failure. 186
Segmental analysis of cardiac metabolism by hyperpolarized [1-13C] pyruvate: an in-vivo 3D MRI study in pigs 186
Endothelial function and vascular oxidative stress in long-lived GH/IGF-deficient Ames dwarf mice. 185
Transthoracic Sensor for Noninvasive Assessment of Left Ventricular Contractility: Validation in A Minipig Model of Chronic Heart Failure. 185
Early long‐term L‐T3 replacement rescues mitochondria and prevents ischemic cardiac remodeling in rats 184
Adeno-associated virus mediated gene delivery into coronary microvessels of chronically instrumented dogs. 183
In vitro system to study realistic pulsatile flow and stretch signaling in cultured vascular cells 183
Combined PET and Tagging-MRI reveal altered patterns of regional function and metabolism in ventricular dyssynchrony. 183
Amlodipine releases nitric oxide (NO) from coronary microvessels after pacing induced dilated cardiomyopathy. 183
Cardiac Metabolism in a Pig Model of Ischemia-Reperfusion by Cardiac Magnetic Resonance with Hyperpolarized 13C-Pyruvate 182
Myocardial substrate metabolism in the normal and failing heart 181
Short Interfering RNA-Mediated Knockdown Of Glucose-6-Phosphate Dehydrogenase Impairs Cardiac Contractile Performance and Efficiency in Conscious Dogs. 181
Overview of ventilator-induced lung injury mechanisms 180
Pacing induced myocardial ischemia in patients with dilated cardiomyopathy. 180
Water-Dispersible Three-Dimensional LC-Nanoresonators 180
Changes in cardiac metabolism produced by acute inhibition of NO synthase can be reversed by a long-acting NO donor 180
Class I histone deacetylase inhibition for the treatment of sustained atrial fibrillation 180
Adverse influence of systemic vascular stiffening on cardiac dysfunction and adaptation to acute coronary occlusion. 179
Superoxide production by NAD(P)H oxidase and mitochondria is increased in genetically obese and hyperglycemic rat heart and aorta before the development of cardiac dysfunction. The role of glucose-6-phosphate dehydrogenase-derived NADPH. 179
Chronic β1-adrenergic blockade enhances myocardial β3-adrenergic coupling with nitric oxide-cGMP signaling in a canine model of chronic volume overload: new insight into mechanisms of cardiac benefit with selective β1-blocker therapy 179
Hyaluronan mixed esters of butyric and retinoic acid affording myocardial survival and repair without stem cell transplantation. 179
Reduced nitric oxide production and altered myocardial metabolism during the decompensation of pacing-induced heart failure in the conscious dog. 178
Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications 178
Early detection of acute lung injury uncoupled to hypoxemia in pigs using ultrasound lung comets. 178
Totale 22.291
Categoria #
all - tutte 201.680
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 201.680


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.665 0 0 0 0 0 578 291 197 278 274 433 614
2021/20223.340 170 615 419 278 65 61 315 592 162 323 81 259
2022/20232.877 233 126 48 605 366 469 36 235 481 69 110 99
2023/20241.082 151 66 203 58 65 161 133 31 13 36 42 123
2024/20256.750 79 62 416 237 188 512 1.024 1.924 552 218 770 768
2025/20268.743 780 2.762 1.614 1.691 1.662 234 0 0 0 0 0 0
Totale 39.523